X

Sign up for Equitymaster's free daily newsletter, The 5 Minute WrapUp and get access to our latest Multibagger guide (2017 Edition) on picking money-making stocks.

This is an entirely free service. No payments are to be made.


Download Now Subscribe to our free daily e-letter, The 5 Minute WrapUp and get this complimentary report.
We hate spam as much as you do. Check out our Privacy Policy and Terms Of Use.
Compare Cadila Healthcare with Fresenius Kabi Onco. - Equitymaster
  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

CADILA HEALTHCARE vs FRESENIUS KABI ONCO. - Comparison Results

CADILA HEALTHCARE    Change

Cadila Healthcare is one of the leading players in the Indian pharma market having a presence in both the domestic and international markets. In the international markets, the company had adopted the strategy of competing directly in the generics mar... More

FRESENIUS KABI ONCO. 
   Change

Fresenius Kabi Oncology is the erstwhile Dabur Pharma, which was incorporated in March 2003. The company is a leading player in oncology in India and the international markets. Fresenius Kabi Oncology operates in the regulated markets namely the US a... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    CADILA HEALTHCARE FRESENIUS KABI ONCO. CADILA HEALTHCARE/
FRESENIUS KABI ONCO.
 
P/E (TTM) x 36.5 22.1 165.1% View Chart
P/BV x 9.4 3.1 302.3% View Chart
Dividend Yield % 0.7 0.0 -  

Financials

 CADILA HEALTHCARE   FRESENIUS KABI ONCO.
EQUITY SHARE DATA
    CADILA HEALTHCARE
Mar-16
FRESENIUS KABI ONCO.
Mar-13
CADILA HEALTHCARE/
FRESENIUS KABI ONCO.
5-Yr Chart
Click to enlarge
High Rs454176 258.2%   
Low Rs30579 387.9%   
Sales per share (Unadj.) Rs96.137.7 255.0%  
Earnings per share (Unadj.) Rs14.95.1 292.0%  
Cash flow per share (Unadj.) Rs17.86.7 265.1%  
Dividends per share (Unadj.) Rs3.200-  
Dividend yield (eoy) %0.80-  
Book value per share (Unadj.) Rs52.342.5 122.9%  
Shares outstanding (eoy) m1,023.74158.23 647.0%   
Bonus/Rights/Conversions FV5:1--  
Price / Sales ratio x3.93.4 116.9%   
Avg P/E ratio x25.525.0 102.1%  
P/CF ratio (eoy) x21.318.9 112.5%  
Price / Book Value ratio x7.33.0 242.7%  
Dividend payout %21.50-   
Avg Mkt Cap Rs m388,45820,135 1,929.3%   
No. of employees `00015.41.2 1,340.4%   
Total wages/salary Rs m13,317703 1,893.8%   
Avg. sales/employee Rs Th6,371.15,176.2 123.1%   
Avg. wages/employee Rs Th862.4610.4 141.3%   
Avg. net profit/employee Rs Th986.1699.6 141.0%   
INCOME DATA
Net Sales Rs m98,3765,963 1,649.8%  
Other income Rs m94118 5,227.8%   
Total revenues Rs m99,3175,981 1,660.5%   
Gross profit Rs m23,8291,430 1,666.2%  
Depreciation Rs m3,022258 1,171.8%   
Interest Rs m486-26 -1,869.2%   
Profit before tax Rs m21,2621,216 1,748.2%   
Minority Interest Rs m-3000-   
Prior Period Items Rs m50-   
Extraordinary Inc (Exp) Rs m-25-68 36.7%   
Tax Rs m5,716342 1,670.4%   
Profit after tax Rs m15,226806 1,889.3%  
Gross profit margin %24.224.0 101.0%  
Effective tax rate %26.928.1 95.5%   
Net profit margin %15.513.5 114.5%  
BALANCE SHEET DATA
Current assets Rs m44,3765,102 869.8%   
Current liabilities Rs m34,0712,385 1,428.3%   
Net working cap to sales %10.545.6 23.0%  
Current ratio x1.32.1 60.9%  
Inventory Days Days54150 35.9%  
Debtors Days Days62113 55.0%  
Net fixed assets Rs m47,8965,148 930.4%   
Share capital Rs m1,024158 647.3%   
"Free" reserves Rs m48,7466,556 743.6%   
Net worth Rs m53,5196,732 795.0%   
Long term debt Rs m8,964952 941.4%   
Total assets Rs m100,16310,388 964.2%  
Interest coverage x44.7-45.8 -97.8%   
Debt to equity ratio x0.20.1 118.4%  
Sales to assets ratio x1.00.6 171.1%   
Return on assets %15.77.5 208.9%  
Return on equity %28.412.0 237.6%  
Return on capital %34.314.6 234.8%  
Exports to sales %45.374.5 60.8%   
Imports to sales %5.924.8 24.0%   
Exports (fob) Rs m44,5374,441 1,003.0%   
Imports (cif) Rs m5,8381,477 395.2%   
Fx inflow Rs m44,8815,298 847.2%   
Fx outflow Rs m9,0691,772 511.7%   
Net fx Rs m35,8123,525 1,015.8%   
CASH FLOW
From Operations Rs m19,9381,274 1,564.9%  
From Investments Rs m-9,039-1,204 750.6%  
From Financial Activity Rs m-9,527-196 4,858.2%  
Net Cashflow Rs m1,372-126 -1,086.3%  

Share Holding

Indian Promoters % 74.8 0.0 -  
Foreign collaborators % 0.0 81.0 -  
Indian inst/Mut Fund % 8.3 0.3 2,766.7%  
FIIs % 5.9 9.6 61.5%  
ADR/GDR % 0.0 0.0 -  
Free float % 11.0 9.1 120.9%  
Shareholders   44,069 42,599 103.5%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare CADILA HEALTHCARE With:   CIPLA  PFIZER  ALKEM LABORATORIES  ORCHID PHARMA LTD  SANOFI INDIA  

Compare CADILA HEALTHCARE With:   MYLAN (US)  ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  TEVA PHARMA (Israel)  



Today's Market

Flat Finish to the Week; Cadila Healthcare Rallies 7%(Closing)

Indian share markets finished marginally higher for the week in a thin trade amid buying in pharma stocks, software stocks and capital good stocks.

Related Views on News

Sun Pharma: Bottomline Slips into the Red Amidst Challenging Environment (Quarterly Results Update - Detailed)

Aug 14, 2017

A challenging environment and one-time expense pushes Sun Pharma into a loss in the first quarter.

Lupin: Bigger Challenges or Bigger Margin of Safety? (Quarterly Results Update - Detailed)

Aug 14, 2017

GST impact coupled with price erosion in US leads to lower profits for the quarter.

Dr Reddy's: US Pressure Continues to Haunt (Quarterly Results Update - Detailed)

Aug 8, 2017

Profits plunge due to higher raw material costs.

Biocon: Lower Licensing Income Leads to Muted Growth for the Quarter (Quarterly Results Update - Detailed)

Jun 23, 2017

Net Profit lower due to exceptional items in the previous year.

The Power of 5 Minutes (The 5 Minute Wrapup)

Jun 16, 2017

Here's what you can expect from The 5 Minute Wrapup in the coming months and years.

More Views on News

Most Popular

This Small Cap Can Drive Chinese Players Out of India (and Make a Fortune in the Process)(The 5 Minute Wrapup)

Aug 17, 2017

A small-cap Indian company with high-return potential and blue-chip-like stability is set to supplant the Chinese players in this niche segment.

Dear PM Modi, India is Already Land of Self-Employed, and It Ain't Working(Vivek Kaul's Diary)

Aug 21, 2017

Most Indians who cannot find jobs, look at becoming self-employed.

It's the Best Time to Buy IT Stocks(Daily Profit Hunter)

Aug 16, 2017

The IT Sector could be in an uptrend till February 2019. Are you prepared to ride the trend?

Think Twice Before You Keep Money In A Savings Bank Account(Outside View)

Aug 22, 2017

Post demonetisation, a cut in bank savings deposits rates was in the offing.

5 Steps To Become Financially Independent(Outside View)

Aug 16, 2017

Ensure your financial Independence, and pledge to start the journey towards financial freedom today!

More

Become A Smarter Investor In
Just 5 Minutes

Multibagger Stocks Guide 2017
Get our special report, Multibagger Stocks Guide (2017 Edition) Now!
We will never sell or rent your email id.
Please read our Terms

CADILA HEALTHCARE SHARE PRICE


Aug 24, 2017 03:36 PM

TRACK CADILA HEALTHCARE

  • Track your investment in CADILA HEALTHCARE with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON CADILA HEALTHCARE

CADILA HEALTHCARE 8-QTR ANALYSIS

COMPARE CADILA HEALTHCARE WITH

MARKET STATS